Actively Recruiting
Pre-exposure Prophylaxis (PrEP) Uptake and Adherence Intervention for Women with Trauma-related Conditions
Led by The University of Texas Health Science Center, Houston · Updated on 2024-12-30
60
Participants Needed
1
Research Sites
38 weeks
Total Duration
On this page
Sponsors
T
The University of Texas Health Science Center, Houston
Lead Sponsor
N
National Institute on Drug Abuse (NIDA)
Collaborating Sponsor
AI-Summary
What this Trial Is About
The investigators have previously developed an integrated bio-behavioral intervention to promote PrEP uptake and adherence in cisgender women who are undergoing treatment for trauma-related mental health conditions and who are at a higher risk for HIV. The intervention is delivered within the mental health treatment setting and integrates knowledge, behavioral skills, and motivation to engage in and adhere to PrEP care. The purpose of this study is to assess the preliminary efficacy, feasibility, and acceptability of this intervention. The hypothesis is that, compared to standard treatment, the intervention will be feasible, acceptable, and associated with greater PrEP uptake and adherence.
CONDITIONS
Official Title
Pre-exposure Prophylaxis (PrEP) Uptake and Adherence Intervention for Women with Trauma-related Conditions
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Currently undergoing mental health treatment
- Have a history of trauma
- HIV negative
- Sexually active with an opposite sex partner within the past 6 months
- Not using PrEP for HIV prevention at the time of screening
- Eligible for PrEP based on having at least one CDC-defined criteria for PrEP
- Fluent in English
- Own or have regular access to a smart phone
You will not qualify if you...
- HIV positive
- Concurrently participating in another HIV prevention program
- Have severe cognitive impairment that interferes with consent, understanding study procedures or participating in therapy
- Have psychological distress that prohibits participation in the study
- Unable or unwilling to meet study requirements
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Louis A. Faillace, MD, Department of Psychiatry and Behavioral Sciences, University of Texas Health Science Center at Houston
Houston, Texas, United States, 77054
Actively Recruiting
Research Team
A
Angela M Heads, PhD
CONTACT
K
Kaixuan An
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here